Romba, Luis, {Stanimir S. } Valtchev, and Rui Melício. "
Single-phase wireless power transfer system controlled by magnetic core reactors at transmitter and receiver."
Technological Innovation for Smart Systems - 8th IFIP WG 5.5/SOCOLNET Advanced Doctoral Conference on Computing, Electrical and Industrial Systems, DoCEIS 2017, Proceedings. IFIP Advances in Information and Communication Technology. Springer New York LLC, 2017. 419-428.
AbstractThe applications of wireless power transmission have become widely increasing over the last decade, mainly in the battery charging systems for electric vehicles. This paper focuses on the single-phase wireless power transfer prototype controlled by magnetic core reactors in either side of the system: that of the transmitter, and that of the receiver. The described wireless power transfer system prototype employs a strong magnetic coupling technology to improve the power transmission efficiency. In the same time, a magnetic core reactor is used to control the “tuning” between the transmitter and the receiver frequencies, allowing for that increase of the system efficiency. Finally, practical results of the implemented prototype are presented.
Duarte, Rui M., Pedro Varanda, Rui L. Reis, Ana Rita C. Duarte, and Jorge Correia-Pinto. "
{Biomaterials and Bioactive Agents in Spinal Fusion}."
Tissue Engineering Part B: Reviews. 23 (2017): ten.teb.2017.0072.
AbstractManagement of degenerative spine pathologies frequently leads to the need for spinal fusion (SF), where bone growth is induced toward stabilization of the interventioned spine. Autologous bone graft (ABG) remains the gold-standard inducer, whereas new bone graft substitutes attempt to achieve effective de novo bone formation and solid fusion. Limited fusion outcomes have driven motivation for more sophisticated and multidisciplinary solutions, involving new biomaterials and/or biologics, through innovative delivery platforms. The present review will analyze the most recent body of literature that is focused on new approaches for consistent bone fusion of spinal vertebrae, including the development of new biomaterials that pursue physical and chemical aptitudes; the delivery of growth factors (GF) to accelerate new bone formation; and the use of cells to improve functional bone development. Bone graft substitutes currently in clinical practice, such as demineralized bone matrix and ceramics, are still used as a starting point for the study of new bioactive agents. Polyesters such as polycaprolactone and polylactic acid arise as platforms for the development of composites, where a mineral element and cell/GF constitute the delivery system. Exciting fusion outcomes were obtained in several small and large animal models with these. On what regards bioactive agents, mesenchymal stem cells, preferentially derived from the bone marrow or adipose tissue, were studied in this context. Autologous and allogeneic approaches, as well as osteogenically differentiated cells, have been tested. These cell sources have further been genetically engineered for specific GF expression. Nevertheless, results on fusion efficacy with cells have been inconsistent. On the other hand, the delivery of GF (most commonly bone morphogenetic protein-2 [BMP-2]) has provided favorable outcomes. Complications related to burst release and dosing are still the target of research through the development of controlled release systems or alternative GF such as Nel-like molecule-1 (NELL-1), Oxysterols, or COMP-Ang1. Promising solutions with new biomaterial and GF compositions are becoming closer to the human patient, as these evidence high-fusion performance, while offering cost and safety advantages. The use of cells has not yet proved solid benefits, whereas a further understanding of cell behavior remains a challenge.